PubMed

Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909.

Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP.

J Clin Oncol. 2009 Nov 16. [Epub ahead of print]PMID: 19917845 [PubMed - as supplied by publisher]Related articles

Epigenetic alterations in a murine model for chronic lymphocytic leukemia.

Chen SS, Sherman MH, Hertlein E, Johnson AJ, Teitell MA, Byrd JC, Plass C.

Cell Cycle. 2009 Nov 15;8(22):3663-7.PMID: 19901553 [PubMed - in process]Related articles

Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.

Byrd JC, Byrd JC, Peterson BL, Rai KR, Byrd JC, Peterson BL, Rai KR, Hurd D, Hohl R, Perry MC, Gockerman J, Nattam S, Larson RA.

Leuk Lymphoma. 2009 Oct;50(10):1589-96.PMID: 19863336 [PubMed - in process]Related articles

Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemia.

Lin TS, Naumovski L, Lecane PS, Lucas MS, Moran ME, Cheney C, Lucas DM, Phan SC, Miller RA, Byrd JC.

Leuk Lymphoma. 2009 Oct 8. [Epub ahead of print]PMID: 19860624 [PubMed - as supplied by publisher]Related articles

A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia.

Lin TS, Stock W, Xu H, Phelps MA, Lucas MS, Guster SK, Briggs BR, Cheney C, Porcu P, Flinn IW, Grever MR, Dalton JT, Byrd JC.

Leuk Lymphoma. 2009 Sep 30. [Epub ahead of print]PMID: 19860603 [PubMed - as supplied by publisher]Related articles

Targeted Delivery of Antisense Oligodeoxynucleotide by Transferrin Conjugated pH-Sensitive Lipopolyplex Nanoparticles: A Novel Oligonucleotide-Based Therapeutic Strategy in Acute Myeloid Leukemia.

Jin Y, Liu S, Yu B, Golan S, Koh CG, Yang J, Huynh L, Yang X, Pang J, Muthusamy N, Chan KK, Byrd JC, Talmon Y, Lee LJ, Lee RJ, Marcucci G.

Mol Pharm. 2009 Nov 6. [Epub ahead of print]PMID: 19852511 [PubMed - as supplied by publisher]Related articles

Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia.

Sanchez-Aguilera A, Rattmann I, Drew DZ, Müller LU, Summey V, Lucas DM, Byrd JC, Croce CM, Gu Y, Cancelas JA, Johnston P, Moritz T, Williams DA.

Leukemia. 2009 Oct 22. [Epub ahead of print]PMID: 19847197 [PubMed - as supplied by publisher]Related articles

Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia.

Byrd JC, Kipps TJ, Flinn IW, Castro J, Lin TS, Wierda W, Heerema N, Woodworth J, Hughes S, Tangri S, Harris S, Wynne D, Molina A, Leigh B, O'Brien S.

Blood. 2009 Oct 20. [Epub ahead of print]PMID: 19843887 [PubMed - as supplied by publisher]Related articles

Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease.

Lin TS, Ruppert AS, Johnson AJ, Fischer B, Heerema NA, Andritsos LA, Blum KA, Flynn JM, Jones JA, Hu W, Moran ME, Mitchell SM, Smith LL, Wagner AJ, Raymond CA, Schaaf LJ, Phelps MA, Villalona-Calero MA, Grever MR, Byrd JC.

J Clin Oncol. 2009 Oct 13. [Epub ahead of print]PMID: 19826119 [PubMed - as supplied by publisher]Related articles

Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.

Hamadani M, Blum W, Phillips G, Elder P, Andritsos L, Hofmeister C, O'Donnell L, Klisovic R, Penza S, Garzon R, Krugh D, Lin T, Bechtel T, Benson DM, Byrd JC, Marcucci G, Devine SM.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1422-30. Epub 2009 Sep 1.PMID: 19822302 [PubMed - in process]Related articles

Flavopiridol in chronic lymphocytic leukemia: a concise review.

Christian BA, Grever MR, Byrd JC, Lin TS.

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S179-85.PMID: 19778838 [PubMed - in process]Related articles

A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors.

Ramaswamy B, Bekaii-Saab T, Schaaf LJ, Lesinski GB, Lucas DM, Young DC, Ruppert AS, Byrd JC, Culler K, Wilkins D, Wright JJ, Grever MR, Shapiro CL.

Cancer Chemother Pharmacol. 2009 Sep 23. [Epub ahead of print]PMID: 19774377 [PubMed - as supplied by publisher]Related articles

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia.

Blum KA, Advani A, Fernandez L, Van Der Jagt R, Brandwein J, Kambhampati S, Kassis J, Davis M, Bonfils C, Dubay M, Dumouchel J, Drouin M, Lucas DM, Martell RE, Byrd JC.

Br J Haematol. 2009 Nov;147(4):507-14. Epub 2009 Aug 31.PMID: 19747365 [PubMed - in process]Related articlesFree article

Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing.

Koh CG, Zhang X, Liu S, Golan S, Yu B, Yang X, Guan J, Jin Y, Talmon Y, Muthusamy N, Chan KK, Byrd JC, Lee RJ, Marcucci G, Lee LJ.

J Control Release. 2009 Aug 28. [Epub ahead of print]PMID: 19716852 [PubMed - as supplied by publisher]Related articles

Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia.

Chen SS, Raval A, Johnson AJ, Hertlein E, Liu TH, Jin VX, Sherman MH, Liu SJ, Dawson DW, Williams KE, Lanasa M, Liyanarachchi S, Lin TS, Marcucci G, Pekarsky Y, Davuluri R, Croce CM, Guttridge DC, Teitell MA, Byrd JC, Plass C.

Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13433-8. Epub 2009 Jul 28.PMID: 19666576 [PubMed - indexed for MEDLINE]Related articles

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

Shanafelt TD, Byrd JC, LaPLant B, Zent CS, Call T, Secreto C, Grever MR, Lin TS, Kay NE.

Br J Haematol. 2009 Sep;146(6):660-4. Epub 2009 Jul 10.PMID: 19604237 [PubMed - in process]Related articles

Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.

Blum KA, Hamadani M, Phillips GS, Lozanski G, Johnson AJ, Lucas DM, Smith LL, Baiocchi R, Lin TS, Porcu P, Devine SM, Byrd JC.

Leuk Lymphoma. 2009 Mar;50(3):349-56.PMID: 19263294 [PubMed - indexed for MEDLINE]Related articles

Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia.

Su X, Lucas DM, Zhang L, Xu H, Zabrouskov V, Davis ME, Knapp AR, Young DC, Payne PR, Parthun MR, Marcucci G, Grever MR, Byrd JC, Freitas MA.

Proteomics. 2009 Mar;9(5):1197-206.PMID: 19253275 [PubMed - indexed for MEDLINE]Related articles

High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor.

Hartman MA, Kreiling JL, Byrd JC, MacDonald RG.

FEBS J. 2009 Apr;276(7):1915-29. Epub 2009 Feb 19.PMID: 19236480 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Woyach JA, Lin TS, Lucas MS, Heerema N, Moran ME, Cheney C, Lucas DM, Wei L, Caligiuri MA, Byrd JC.

Leukemia. 2009 May;23(5):912-8. Epub 2009 Feb 19.PMID: 19225537 [PubMed - indexed for MEDLINE]Related articles